Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from Jagdish Agrawal
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Drugs & Industries Ltd has informed the stock exchanges that it has received a disclosure under Regulation 29(2) of the SEBI Takeover Regulations from Jagdish Agrawal. This type of disclosure is made by a shareholder when their shareholding changes by more than 2% in one transaction or over a financial year. The filing confirms regulatory compliance but the headline alone does not specify whether the transaction was a purchase or sale, nor the exact number of shares or percentage change involved.
Shareholders should watch for further details, as such disclosures from promoter-group individuals can signal changes in promoter holding that may influence share price sentiment.